Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Bolenz C

Collect these papers and discover other ones on Labmeeting. Learn more.

Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer.

+ cite this

+ View Abstract

Roscigno M, Shariat SF, Freschi M, Margulis V, Karakiewizc P, Suardi N, Remzi M, Zigeuner R, Bolenz C, Kikuchi E, Weizer A, Bensalah K, Sagalowsky A, Koppie TM, Raman J, Fernández M,

(show remaining authors)

Urology 74(5):1070-4, 2009 Nov - Who cited this? | PubMed ID: 19883824 | Fulltext

Endothelin-A-receptor antagonism with atrasentan exhibits limited activity on the KU-19-19 bladder cancer cell line in a mouse model.

+ cite this

+ View Abstract

Herrmann E, Tiemann A, Eltze E, Bolenz C, Bremer C, Persigehl T, Hertle L, and Wülfing C

Journal of cancer research and clinical oncology 135(10):1455-62, 2009 Oct - Who cited this? | PubMed ID: 19430814 | Fulltext

Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the upper tract urothelial carcinoma collaboration.

+ cite this

+ View Abstract

Hellenthal NJ, Shariat SF, Margulis V, Karakiewicz PI, Roscigno M, Bolenz C, Remzi M, Weizer A, Zigeuner R, Bensalah K, Ng CK, Raman JD, Kikuchi E, Montorsi F, Oya M, Wood CG,

(show remaining authors)

The Journal of urology 182(3):900-6, 2009 Sep - Who cited this? | PubMed ID: 19616245 | Fulltext

The role of lymphangiogenesis in lymphatic tumour spread of urological cancers.

+ cite this

+ View Abstract

Bolenz C, Fernández MI, Tilki D, Herrmann E, Heinzelbecker J, Ergün S, Ströbel P, Reich O, Michel MS, and Trojan L

BJU international 104(5):592-7, 2009 Sep - Who cited this? | PubMed ID: 19594740 | Fulltext

The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed?.

+ cite this

+ View Abstract

Roscigno M, Shariat SF, Margulis V, Karakiewicz P, Remzi M, Kikuchi E, Zigeuner R, Weizer A, Sagalowsky A, Bensalah K, Raman JD, Bolenz C, Kassou W, Koppie TM, Wood CG, Wheat J,

(show remaining authors)

European urology 56(3):512-8, 2009 Sep - Who cited this? | PubMed ID: 19559518 | Fulltext

Impact of body mass index on clinical and cost outcomes after radical cystectomy.

+ cite this

+ View Abstract

Bagrodia A, Grover S, Srivastava A, Gupta A, Bolenz C, Sagalowsky AI, and Lotan Y

BJU international 104(3):326-30, 2009 Aug - Who cited this? | PubMed ID: 19220244 | Fulltext

Re: Pathologic stage T2a and T2b prostate cancer in the recent prostate-specific antigen era: implications for unilateral ablative therapy.

+ cite this

Bolenz C and Pelzer AE

European urology 56(2):396, 2009 Aug - Who cited this? | PubMed ID: 19691135 | Fulltext

Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.

+ cite this

+ View Abstract

Shariat SF, Bolenz C, Godoy G, Fradet Y, Ashfaq R, Karakiewicz PI, Isbarn H, Jeldres C, Rigaud J, Sagalowsky AI, and Lotan Y

The Journal of urology 182(1):78-84; discussion 84, 2009 Jul - Who cited this? | PubMed ID: 19447418 | Fulltext

Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.

+ cite this

+ View Abstract

Roscigno M, Shariat SF, Margulis V, Karakiewicz P, Remzi M, Kikuchi E, Langner C, Lotan Y, Weizer A, Bensalah K, Raman JD, Bolenz C, Guo CC, Wood CG, Zigeuner R, Wheat J,

(show remaining authors)

The Journal of urology 181(6):2482-9, 2009 Jun - Who cited this? | PubMed ID: 19371878 | Fulltext

Interobserver variation in grading and staging of squamous cell carcinoma of the penis in relation to the clinical outcome.

+ cite this

+ View Abstract

Naumann CM, Alkatout I, Hamann MF, Al-Najar A, Hegele A, Korda JB, Bolenz C, Klöppel G, Jünemann KP, and van der Horst C

BJU international 103(12):1660-5, 2009 Jun - Who cited this? | PubMed ID: 19220243 | Fulltext

Lymphatic spread in squamous cell carcinoma of the penis is independent of elevated lymph vessel density.

+ cite this

+ View Abstract

Naumann CM, Al-Najar A, Alkatout I, Hegele A, Korda JB, Bolenz C, Kalthoff H, Sipos B, Juenemann KP, and van der Horst C

BJU international 103(12):1655-9, 2009 Jun - Who cited this? | PubMed ID: 19220258 | Fulltext

In vivo evaluation of intravesical paclitaxel and combined bcl-xL antisense oligodeoxynucleotide treatment for orthotopic urothelial carcinoma.

+ cite this

+ View Abstract

Bolenz C, Weiss C, Wenzel M, Gabriel U, Steidler A, Becker A, Herrmann E, Trojan L, and Michel MS

Journal of cancer research and clinical oncology 135(5):679-86, 2009 May - Who cited this? | PubMed ID: 18941779 | Fulltext

Clinical staging error in prostate cancer: localization and relevance of undetected tumour areas.

+ cite this

+ View Abstract

Bolenz C, Gierth M, Grobholz R, Köpke T, Semjonow A, Weiss C, Alken P, Michel MS, and Trojan L

BJU international 103(9):1184-9, 2009 May - Who cited this? | PubMed ID: 19154463 | Fulltext

Lymphangiogenesis occurs in upper tract urothelial carcinoma and correlates with lymphatic tumour dissemination and poor prognosis.

+ cite this

+ View Abstract

Bolenz C, Fernández MI, Trojan L, Hoffmann K, Herrmann E, Steidler A, Weiss C, Ströbel P, Alken P, and Michel MS

BJU international 103(8):1040-6, 2009 Apr - Who cited this? | PubMed ID: 18990139 | Fulltext

Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma.

+ cite this

+ View Abstract

Kikuchi E, Margulis V, Karakiewicz PI, Roscigno M, Mikami S, Lotan Y, Remzi M, Bolenz C, Langner C, Weizer A, Montorsi F, Bensalah K, Koppie TM, Fernández MI, Raman JD, Kassouf W,

(show remaining authors)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 27(4):612-8, 2009 Feb 1 - Who cited this? | PubMed ID: 19075275 | Fulltext

Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients.

+ cite this

+ View Abstract

Remzi M, Haitel A, Margulis V, Karakiewizc P, Montorsi F, Kikuchi E, Zigeuner R, Weizer A, Bolenz C, Bensalah K, Suardi N, Raman JD, Lotan Y, Waldert M, Ng CK, Fernández M,

(show remaining authors)

BJU international 103(3):307-11, 2009 Feb - Who cited this? | PubMed ID: 18990163 | Fulltext

Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density.

+ cite this

+ View Abstract

Bolenz C, Shariat SF, Fernández MI, Margulis V, Lotan Y, Karakiewicz P, Remzi M, Kikuchi E, Zigeuner R, Weizer A, Montorsi F, Bensalah K, Wood CG, Roscigno M, Langner C, Koppie TM,

(show remaining authors)

BJU international 103(3):302-6, 2009 Feb - Who cited this? | PubMed ID: 18990164 | Fulltext

Decision making in the management of renal cell carcinoma: can nomograms assist?.

+ cite this

Bolenz C and Lotan Y

European urology 55(2):296-8; discussion 298-9, 2009 Feb - Who cited this? | PubMed ID: 18771847 | Fulltext

[Medical treatment of metastatic renal cell carcinoma after the approval and market entry of multitargeted tyrosine kinase inhibitors in Germany.].

+ cite this

+ View Abstract

Bolenz C, Trojan L, Honeck P, Schöppler G, Herrmann E, Alken P, Michel MS, and Häcker A

Aktuelle Urologie 40(1):31-6, 2009 Jan - Who cited this? | PubMed ID: 19177319 | Fulltext

Magnetic resonance imaging as a technique for assessing noninvasive tissue ablation using high-intensity ultrasound: an experimental study.

+ cite this

+ View Abstract

Honeck P, Peters K, Wendt-Nordahl G, Bolenz C, Alken P, Michel MS, Jenne JW, and Häcker A

Journal of endourology / Endourological Society 23(1):161-8, 2009 Jan - Who cited this? | PubMed ID: 19178176 | Fulltext

Outcome of sigmoid compared to ileal orthotopic bladder substitution in terms of micturition and defecation parameters in an 8-year long-term follow-up.

+ cite this

+ View Abstract

Honeck P, Bolenz C, Wendt-Nordahl G, Alken P, and Michel MS

Urologia internationalis 83(3):277-80, 2009 - Who cited this? | PubMed ID: 19829024 | Fulltext

Evaluation of cytotoxic effects induced by bcl-2 and bcl-xL antisense-oligodeoxynucleotides in normal urothelium and transitional cell carcinoma.

+ cite this

+ View Abstract

Gabriel U, Bolenz C, Becker A, Schaaf A, Steidler A, Trojan L, Weiss C, and Michel MS

Oncology reports 20(6):1419-23, 2008 Dec - Who cited this? | PubMed ID: 19020723 | Fulltext

Molecular biomarkers for urothelial carcinoma of the bladder: challenges in clinical use.

+ cite this

+ View Abstract

Bolenz C and Lotan Y

Nature clinical practice. Urology 5(12):676-85, 2008 Dec - Who cited this? | PubMed ID: 19050710 | Fulltext

Evidence-based Sex-related Outcomes After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: Results of Large Multicenter Study.

+ cite this

+ View Abstract

Fernández MI, Shariat SF, Margulis V, Bolenz C, Montorsi F, Suardi N, Remzi M, Wood CG, Roscigno M, Kikuchi E, Oya M, Zigeuner R, Langner C, Weizer A, Lotan Y, Koppie TM,

(show remaining authors)

Urology, 2008 Oct 7 - Who cited this? | PubMed ID: 18845322 | Fulltext

Carcinoma in situ of the Upper Urinary Tract Treated with Radical Nephroureterectomy - Results from a Multicenter Study.

+ cite this

Karam JA, Margulis V, Montorsi F, Karakiewicz PI, Lotan Y, Kikuchi E, Weizer A, Zigeuner R, Bolenz C, and Shariat SF

European urology 54(4):961-3, 2008 Oct - Who cited this? | PubMed ID: 18485573 | Fulltext

Words of wisdom. Re: Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial. Escudier B, Pluzanska A, Koralewski P, et al., for the AVOREN Trial investigators.

+ cite this

Shariat SF, Bolenz C, and Karakiewicz PI

European urology 54(4):948-9, 2008 Oct - Who cited this? | PubMed ID: 18953756 | Fulltext

Cellular uptake and ex vivo urothelial penetration by oligodeoxynucleotides for optimizing treatment of transitional cell carcinoma.

+ cite this

+ View Abstract

Bolenz C, Trojan L, Gabriel U, Honeck P, Wendt-Nordahl G, Schaaf A, Alken P, and Michel MS

Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 30(5):265-73, 2008 Oct - Who cited this? | PubMed ID: 18980158 | Fulltext

Lymphovascular invasion and pathologic tumor stage are significant outcome predictors for patients with upper tract urothelial carcinoma.

+ cite this

+ View Abstract

Bolenz C, Fernández MI, Trojan L, Herrmann E, Becker A, Weiss C, Alken P, Ströbel P, and Michel MS

Urology 72(2):364-9, 2008 Aug - Who cited this? | PubMed ID: 18579189 | Fulltext

Topical Chemotherapy in Human Urothelial Carcinoma Explants: A Novel Translational Tool for Preclinical Evaluation of Experimental Intravesical Therapies.

+ cite this

+ View Abstract

Bolenz C, Ikinger EM, Ströbel P, Trojan L, Steidler A, Fernández MI, Honeck P, Gabriel U, Weiss C, Grobholz R, Alken P, and Michel MS

European urology, 2008 Jul 30 - Who cited this? | PubMed ID: 18691807 | Fulltext

Pre-treatment global quality of health predicts progression free survival in metastatic kidney cancer patients treated with sorafenib or sunitinib.

+ cite this

+ View Abstract

Herrmann E, Gerss J, Bierer S, Köpke T, Bolenz C, Hertle L, and Wülfing C

Journal of cancer research and clinical oncology, 2008 Jul 1 - Who cited this? | PubMed ID: 18592270 | Fulltext

[Solitary fibrous Tumour of the Testes (SFT).].

+ cite this

+ View Abstract

Honeck P, Ströbel P, Michel MS, Bolenz C, Wendt-Nordahl G, Alken P, and Häcker A

Aktuelle Urologie 39(4):305, 2008 Jul - Who cited this? | PubMed ID: 18663673 | Fulltext

The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer.

+ cite this

+ View Abstract

Herrmann E, Stöter E, van Ophoven A, Bierer S, Bolenz C, Hertle L, and Wülfing C

International journal of urology : official journal of the Japanese Urological Association 15(7):607-11, 2008 Jul - Who cited this? | PubMed ID: 18462352 | Fulltext

Lymph-node metastases in intermediate-risk squamous cell carcinoma of the penis.

+ cite this

+ View Abstract

Naumann CM, Alkatout I, Al-Najar A, Korda JB, Hegele A, Bolenz C, Ziegler H, Klöppel G, Juenemann KP, and van der Horst C

BJU international, 2008 May 16 - Who cited this? | PubMed ID: 18489528 | Fulltext

Hemostatic Properties of Four Devices for Partial Nephrectomy: A Comparative ex Vivo Study.

+ cite this

+ View Abstract

Honeck P, Wendt-Nordahl G, Bolenz C, Peters T, Weiss C, Alken P, Michel MS, and Häcker A

Journal of endourology / Endourological Society 22(5):1071-6, 2008 May - Who cited this? | PubMed ID: 18429683 | Fulltext

Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder.

+ cite this

+ View Abstract

Fernández MI, Bolenz C, Trojan L, Steidler A, Weiss C, Alken P, Grobholz R, and Michel MS

European urology 53(3):571-80, 2008 Mar - Who cited this? | PubMed ID: 17804149 | Fulltext

Evaluation of cystine transport in cultured human kidney cells and establishment of cystinuria type I phenotype by antisense technology.

+ cite this

+ View Abstract

Wendt-Nordahl G, Sagi S, Bolenz C, Alken P, Michel MS, and Knoll T

Urological research 36(1):25, 2008 Feb - Who cited this? | PubMed ID: 18074125 | Fulltext

[Complications and side effects of low dose rate brachytherapy for the treatment of prostate cancer: data on a 13 year follow-up study from Mannheim].

+ cite this

+ View Abstract

Trojan L, Harrer K, Schäfer J, Voss M, Welzel G, Bolenz C, Wenz F, Alken P, and Michel MS

Der Urologe. Ausg. A 46(11):1542-7, 2007 Nov - Who cited this? | PubMed ID: 17622506 | Fulltext

[New markers for pharmacological targeting in bladder cancer with lymph node metastasis].

+ cite this

+ View Abstract

Herrmann E, Eltze E, Köpke T, Bolenz C, Bierer S, Neumann J, Hertle L, and Wülfing C

Aktuelle Urologie 38(5):392-7, 2007 Sep - Who cited this? | PubMed ID: 17907066 | Fulltext

Newly developed mini-endoscope for diagnosis and follow-up of orthotopic bladder transitional-cell carcinoma in vivo.

+ cite this

+ View Abstract

Bolenz C, Wenzel M, Cao Y, Trojan L, Häcker A, Arancibia MF, Alken P, and Michel MS

Journal of endourology / Endourological Society 21(7):789-94, 2007 Jul - Who cited this? | PubMed ID: 17705773 | Fulltext

The modern management of upper tract urothelial cancer: surgical treatment.

+ cite this

Arancibia MF, Bolenz C, Michel MS, Keeley FX, and Alken P

BJU international 99(5):978-81, 2007 May - Who cited this? | PubMed ID: 17437429 | Fulltext

Experimental models for therapeutic studies of transitional cell carcinoma.

+ cite this

+ View Abstract

Gabriel U, Bolenz C, and Michel MS

Anticancer research 27(5A):3163-71, 2007 - Who cited this? | PubMed ID: 17970057 | Fulltext

Optimizing chemotherapy for transitional cell carcinoma by application of bcl-2 and bcl-xL antisense oligodeoxynucleotides.

+ cite this

+ View Abstract

Bolenz C, Becker A, Trojan L, Schaaf A, Cao Y, Weiss C, Alken P, and Michel MS

Urologic oncology 25(6):476-82, 2007 - Who cited this? | PubMed ID: 18047955 | Fulltext

Intravesical mitomycin C for superficial transitional cell carcinoma.

+ cite this

+ View Abstract

Bolenz C, Cao Y, Arancibia MF, Trojan L, Alken P, and Michel MS

Expert review of anticancer therapy 6(8):1273-82, 2006 Aug - Who cited this? | PubMed ID: 16925493 | Fulltext

Late results after extended pulmonary artery reconstruction in the arterial switch operation.

+ cite this

+ View Abstract

Ullmann MV, Gorenflo M, Bolenz C, Sebening C, Goetze M, Arnold R, Ulmer HE, and Hagl S

The Annals of thoracic surgery 81(6):2259-66, 2006 Jun - Who cited this? | PubMed ID: 16731163 | Fulltext

Search Google Scholar for Bolenz C

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!